FDA 510(k) · Microlife Intellectual Property

K100763: MICROLIFE UPPER ARM AUTOMATIC DIGITAL BLOOD PRESSURE MONITOR, MODEL WATCH BP HOME N BP3MX1-4 (Microlife Intellectual Property GmbH)

Microlife Intellectual Property GmbH received FDA 510(k) K100763 for MICROLIFE UPPER ARM AUTOMATIC DIGITAL BLOOD PRESSURE MONITOR, MODEL WATCH BP HOME N BP3MX1-4, with a decision date of Aug 27, 2010 (substantially equivalent).

Prescription or OTC: Unknown (no FDA document we parsed states it).

FDA record for K100763FDA summary or statement (PDF)

FDA facts

Official fields for K100763
FDA numberK100763
Pathway510(k)
ApplicantMicrolife Intellectual Property GmbH
Device nameMICROLIFE UPPER ARM AUTOMATIC DIGITAL BLOOD PRESSURE MONITOR, MODEL WATCH BP HOME N BP3MX1-4
Product codeDXN: System, Measurement, Blood-Pressure, Non-Invasive
Regulation (21 CFR)870.1130
Device classClass 2
Date receivedMar 17, 2010
Decision dateAug 27, 2010
DecisionSubstantially Equivalent (SESE)
510(k) typeSpecial

Source: openFDA device 510(k) data, data through Oct 26, 2026.

Indications for use parsed from FDA documents

510(k) Number (if known): 7 '3 Device Name: Microlife Upper Arm Automatic Digital Blood Pressure Monitor, Model WatchBP Home N (BP3MX1-4) Indications For Use: The Microlife Upper Arm Automatic Digital Blood Pressure Monitor, Model WatchBP Home N (BP3MXI -4) is a device intended to measure the systolic and diastolic blood pressure and pulse rate of an adult individual by using a non-invasive oscillometric technique in which an inflatable cuff is wrapped around the upper arm. The device detects the appearance of atrial fibrillation during measurement and gives a warning signal with the reading once the atrial fibrillation is detected. The device can be used in connection with your personal computer (PC) running the WatchBP Analyzer Home N software. The memory data can be transferred to the PC by connecting the monitor via cable with the PC. Prescription Use _X ANDIOR Over-The-Counter Use ___ (Part 21 CFR 801 Sub~part 0-) (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) Concurrence of CDRH,.Office of Device Evaluation (ODE) (Divslon Sign-off) Division of Cardiovascular Devices Page 1 of I 510(k) Number__LCQJjJ~~

Extracted automatically from FDA's 510(k) summary. It can contain extraction errors and is not a verified quote. Read the wording in the FDA PDF before relying on it.

Predicates parsed from FDA documents

FDA numbers found next to the word "predicate" in the summary. The list can include reference devices; check the PDF for which device is the primary predicate.

  • K073198 MICROLIFE UPPER ARM AUTOMATIC DIGITAL B… (Microlife Intellectual Property)
  • K080337

ChatPPG interpretation

A 510(k) decision of "substantially equivalent" means FDA found the device as safe and effective as a legally marketed predicate. FDA's word for this is cleared, not approved. The clearance covers the device and indications in this submission; it does not extend to other features or versions of the same product that were not part of it. See FDA cleared vs approved.

Product code DXN is "System, Measurement, Blood-Pressure, Non-Invasive", class 2, 21 CFR 870.1130.

Our labels for filtering: claim Blood pressure, sensor Cuff. These are heuristics, not FDA fields.